Author is long Hims & Hers, citing 35% short interest, solid growth, and brand as a moat across telehealth verticals.
HIMS — LONG Author is buying Hims & Hers and plans to keep buying as it goes lower, citing 35% short interest and solid growth. The business spans online therapy, telehealth, hair, weight loss, and erectile dysfunction offerings. Author acknowledges critics say the company has no moat but argues the brand itself is the moat. No specific catalyst or timeframe is stated.
I plan to keep buying more as it goes lower. This stock has 35% short interest. Growth is still very solid.
This Reddit post, published January 15, 2026, features u/bpnelson12 discussing HIMS. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/bpnelson12 · Tickers: HIMS